Page 7 - Biological E News Today

Biological E's COVID-19 vaccine Corbevax is administered through intramuscular route with two doses scheduled 28 days apart.

Biological-E, Corbevax, COVID-19, Vaccination, covid, vaccine, vaccine for children, DCGI, Drugs Controller General of India, Subject Expert Committee, SEC

Reifman opens up a plethora of relevant issues like the strategic significance and growing strength of the Indo-US relationship

The Drugs Controller General Of India (DCGI) has already approved Corbevax for restricted use in emergency situation among adults on December 28.

Biological E has sought emergency use authorisation from India's drug regulator for its Covid-19 vaccine Corbevax for the 12 to 18 years age group.

The first batch of COVID-19 vaccines that are part of the Quad group of countries' pledge to donate shots across the world, manufactured by India's Biological E, will roll out in the first half of 2022, the grouping said in a statement on Friday.

Titos: Shots on us.

Our understanding is that Bio E is ready with 100 mn doses, and it is manufacturing 100 mn doses with a target of 1.2 bn doses in 2022, says Peter Hotez, co-developer of Corbevax

India is the furthest along with our partners, biological e, one of the strong vaccine producers in india. they have an advanced purchase for 300 million doses from the indian government. they already have 150 million doses ready to go that just got released for emergency use authorization. and the irony is right now, weve just matched the u.s. government commitment to global health equity for vaccines. were at the same level. we need to do this, heres why. besides the obvious humanitarian drive...

Technology so it really does check all of the boxes for a global health vaccine and our covid vaccine is the first vaccine specifically designed for global health for use in resource settings and we have a tremendous partner, when i say we, our texas childrens center for vaccine development, co-headed by myself and my partner for the last years, we transferred the technology to four or five big vaccine producers in the southern hemisphere and this is known as biological e, based in hyderabad, on...